Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 46.93% is in line with its 5-year average of 47.10%, around the middle of its 5-year range (38.80%–50.99%).
2.56% above its 12-month average of 45.76%.
Reported quarterly gross margin; no daily interpolation. Q4 FY2026 (2026-05-31): 47.85%.
GROSS MARGIN
46.93%
GROSS MARGIN AVG TTM
45.76%
GROSS MARGIN AVG 3Y
46.00%
GROSS MARGIN AVG 5Y
47.10%
GROSS MARGIN AVG 10Y
46.98%
GROSS MARGIN AVG 15Y
48.18%
GROSS MARGIN AVG 20Y
48.99%
CURRENT VS TTM AVG
+2.56%
CURRENT VS 3Y AVG
+2.02%
CURRENT VS 5Y AVG
-0.37%
CURRENT VS 10Y AVG
-0.10%
CURRENT VS 15Y AVG
-2.59%
CURRENT VS 20Y AVG
-4.21%
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+13.41%
vs the sector median at left
Neogen Corporation
Market Cap
$2.66B
Gross Margin
46.93%
TTM Avg
45.76%
3Y Avg
46.00%
5Y Avg
47.10%
Market Cap
$2.66B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.66B
Gross Margin
31.95%
TTM Avg
33.09%
3Y Avg
31.97%
5Y Avg
31.83%
Market Cap
$2.69B
Gross Margin
17.61%
TTM Avg
20.09%
3Y Avg
39.91%
5Y Avg
58.59%
Market Cap
$2.61B
Gross Margin
84.05%
TTM Avg
-197.31%
3Y Avg
-176.53%
5Y Avg
-71811.06%
Market Cap
$2.57B
Gross Margin
7.61%
TTM Avg
10.03%
3Y Avg
9.93%
5Y Avg
9.40%
Market Cap
$2.52B
Gross Margin
92.15%
TTM Avg
99.87%
3Y Avg
99.94%
5Y Avg
66.62%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neogen Corporation (NEOG) | $2.66B | 46.93% | 45.76% | 46.00% | 47.10% |
| MBX Biosciences, Inc. Common Stock (MBX)vs › | $2.66B | 0.00% | 0.00% | 0.00% | 0.00% |
| Aveanna Healthcare Holdings Inc. (AVAH)vs › | $2.66B | 31.95% | 33.09% | 31.97% | 31.83% |
| Acadia Healthcare Company, Inc. (ACHC)vs › | $2.69B | 17.61% | 20.09% | 39.91% | 58.59% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.61B | 84.05% | -197.31% | -176.53% | -71811.06% |
| Precigen, Inc. (PGEN)vs › | $2.71B | 37.05% | 14.17% | 26.62% | -34.97% |
| Privia Health Group, Inc. (PRVA)vs › | $2.57B | 7.61% | 10.03% | 9.93% | 9.40% |
| NewAmsterdam Pharma Company N.V. (NAMS)vs › | $2.52B | 92.15% | 99.87% | 99.94% | 66.62% |
| AtriCure, Inc. (ATRC)vs › | $2.79B | 76.16% | 74.55% | 74.69% | 74.35% |
| TransMedics Group, Inc. (TMDX)vs › | $2.80B | 58.69% | 59.64% | 63.22% | 64.62% |
Gross Margin
46.9%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-05-31 | 47.85% |
| 2026-02-28 | 46.88% |
| 2025-11-30 | 47.48% |
| 2025-08-31 | 45.40% |
| 2025-05-31 | 41.18% |
| 2025-02-28 | 39.35% |
| 2024-11-30 | 38.80% |
| 2024-08-31 | 39.84% |
| 2024-05-31 | 47.92% |
| 2024-02-29 | 50.53% |
| 2023-11-30 | 50.85% |
| 2023-08-31 | 50.99% |
| 2023-05-31 | 50.94% |
| 2023-02-28 | 49.47% |
| 2022-11-30 | 48.92% |
| 2022-08-31 | 47.05% |
| 2022-05-31 | 46.40% |
| 2022-02-28 | 44.77% |
| 2021-11-30 | 46.43% |
| 2021-08-31 | 46.77% |
| 2021-05-31 | 45.27% |
| 2021-02-28 | 46.14% |
| 2020-11-30 | 46.27% |
| 2020-08-31 | 46.01% |
| 2020-05-31 | 47.43% |
| 2020-02-29 | 45.39% |
| 2019-11-30 | 47.33% |
| 2019-08-31 | 47.52% |
| 2019-05-31 | 46.04% |
| 2019-02-28 | 45.68% |
| 2018-11-30 | 46.72% |
| 2018-08-31 | 46.90% |
| 2018-05-31 | 45.38% |
| 2018-02-28 | 47.00% |
| 2017-11-30 | 47.91% |
| 2017-08-31 | 47.69% |
| 2017-05-31 | 47.57% |
| 2017-02-28 | 46.25% |
| 2016-11-30 | 48.05% |
| 2016-08-31 | 48.39% |
| 2016-05-31 | 46.46% |
| 2016-02-29 | 45.87% |
| 2015-11-30 | 48.01% |
| 2015-08-31 | 50.48% |
| 2015-05-31 | 47.96% |
| 2015-02-28 | 49.27% |
| 2014-11-30 | 49.97% |
| 2014-08-31 | 50.41% |
| 2014-05-31 | 47.63% |
| 2014-02-28 | 49.53% |
| 2013-11-30 | 49.48% |
| 2013-08-31 | 51.86% |
| 2013-05-31 | 50.67% |
| 2013-02-28 | 53.50% |
| 2012-11-30 | 53.82% |
| 2012-08-31 | 53.28% |
| 2012-05-31 | 49.23% |
| 2012-02-29 | 50.97% |
| 2011-11-30 | 50.47% |
| 2011-08-31 | 50.28% |
| 2011-05-31 | 50.35% |
| 2011-02-28 | 48.75% |
| 2010-11-30 | 51.19% |
| 2010-08-31 | 53.04% |
| 2010-05-31 | 50.47% |
| 2010-02-28 | 51.61% |
| 2009-11-30 | 52.54% |
| 2009-08-31 | 53.39% |
| 2009-05-31 | 50.10% |
| 2009-02-28 | 46.79% |
| 2008-11-30 | 51.70% |
| 2008-08-31 | 51.39% |
| 2008-05-31 | 52.00% |
| 2008-02-29 | 50.29% |
| 2007-11-30 | 52.08% |
| 2007-08-31 | 53.68% |
| 2007-05-31 | 51.09% |
| 2007-02-28 | 52.01% |
| 2006-11-30 | 52.76% |
| 2006-08-31 | 51.04% |
| 2006-05-31 | 51.24% |
| 2006-02-28 | 48.46% |
| 2005-11-30 | 51.98% |
| 2005-08-31 | 52.69% |
| 2005-05-31 | 50.26% |
| 2005-02-28 | 48.31% |
| 2004-11-30 | 47.24% |
| 2004-08-31 | 49.34% |
| 2004-05-31 | 47.84% |
| 2004-02-29 | 47.06% |
| 2003-11-30 | 52.87% |
| 2003-08-31 | 51.17% |
| 2003-05-31 | 52.87% |
| 2003-02-28 | 51.71% |
| 2002-11-30 | 54.66% |
| 2002-08-31 | 53.38% |
